Document is current
Any future updates will be listed below
-
Authors
Lin, Meng
Xian, Huifang
Chen, Zhanghua https://orcid.org/0000-0002-2505-0675
Wang, Shang
Liu, Ming
Liang, Weiwei
Tang, Qin
Liu, Yao
Huang, Wanming
Che, Di
Guo, Caiqin
Idiiatullina, Elina https://orcid.org/0000-0001-5324-2896
Fang, Rongli
AL-Azab, Mahmoud
Chang, Jingjie https://orcid.org/0000-0002-3191-6746
Wang, Rongze
Li, Xiaojun
Zuo, Xiaoyu
Zhang, Yan
Zhao, Jincun https://orcid.org/0000-0003-2515-5589
Tang, Yaping https://orcid.org/0000-0002-0445-4072
Jin, Shouheng https://orcid.org/0000-0002-2728-2859
He, Zhengjie https://orcid.org/0000-0003-1900-0249
Feng, Du https://orcid.org/0000-0002-2489-4702
Lu, Liwei https://orcid.org/0000-0002-8634-0967
Zhang, Kang https://orcid.org/0000-0002-4549-1697
Wu, Yan
Bai, Fan https://orcid.org/0000-0001-6119-8936
Lew, Andrew M.
Cui, Jun https://orcid.org/0000-0002-8000-3708
Wu, Yuzhang https://orcid.org/0000-0002-4049-0214
Gu, Xiaoqiong https://orcid.org/0000-0002-9558-4226
Zhang, Yuxia https://orcid.org/0000-0003-2715-0925
- License Information
-
More Information
Article History
Received: 6 December 2022
Accepted: 3 July 2023
First Online: 11 August 2023
Competing interests
: Yuxia Zhang, M. Lin, H.X., Z.H., F.B., J.C. and X.G. declare application of patents: use of MCM8-cGAS-STING-I-type interferon signal pathway as disease target (CN202110959959.8, authorized; CN202310692614.x, submitted; PCT/CN2021/113811, submitted; US18022505, submitted; EP21857767.4, submitted), by the Guangzhou Women and Children’s Medical Center. Patent contents include use of MCM8 or its fragments to enhance MCM8-mediated mitophagy for therapeutic purposes in diseases.
